The PEARL 8.0 Post-Approval Study

Clinical trial NCT01845103 · TERMINATED

Trial details

NCT number: NCT01845103
Sponsor: Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.
Status: TERMINATED
Study type: OBSERVATIONAL

Class IV Angina

Start date: 2013-09-01
Primary completion: 2014-12-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.